These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 32239429)

  • 1. Small molecule tyrosine kinase inhibitors in glioblastoma.
    Kim G; Ko YT
    Arch Pharm Res; 2020 Apr; 43(4):385-394. PubMed ID: 32239429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small Molecule Tyrosine Kinase Inhibitors (TKIs) for Glioblastoma Treatment.
    Frumento D; Grossi G; Falesiedi M; Musumeci F; Carbone A; Schenone S
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small-Molecule Inhibitors of Shp2 Phosphatase as Potential Chemotherapeutic Agents for Glioblastoma: A Minireview.
    Mitra R; Ayyannan SR
    ChemMedChem; 2021 Mar; 16(5):777-787. PubMed ID: 33210828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in the development of dual VEGFR and c-Met small molecule inhibitors as anticancer drugs.
    Zhang J; Jiang X; Jiang Y; Guo M; Zhang S; Li J; He J; Liu J; Wang J; Ouyang L
    Eur J Med Chem; 2016 Jan; 108():495-504. PubMed ID: 26717201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HER1/EGFR tyrosine kinase inhibitors for the treatment of glioblastoma multiforme.
    Raizer JJ
    J Neurooncol; 2005 Aug; 74(1):77-86. PubMed ID: 16078112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ABC transporters in multi-drug resistance and ADME-Tox of small molecule tyrosine kinase inhibitors.
    Deng J; Shao J; Markowitz JS; An G
    Pharm Res; 2014 Sep; 31(9):2237-55. PubMed ID: 24842659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Battling Glioblastoma: A Novel Tyrosine Kinase Inhibitor with Multi-Dimensional Anti-Tumor Effect (Running Title: Cancer Cells Death Signalling Activation).
    Viswanathan A; Musa A; Murugesan A; Vale JR; Afonso CAM; Konda Mani S; Yli-Harja O; Candeias NR; Kandhavelu M
    Cells; 2019 Dec; 8(12):. PubMed ID: 31842391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of Small-Molecule Inhibitors of the HSP90-Calcineurin-NFAT Pathway against Glioblastoma.
    Liu Z; Li H; He L; Xiang Y; Tian C; Li C; Tan P; Jing J; Tian Y; Du L; Huang Y; Han L; Li M; Zhou Y
    Cell Chem Biol; 2019 Mar; 26(3):352-365.e7. PubMed ID: 30639261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unlocking Hope: Anti-VEGFR inhibitors and their potential in glioblastoma treatment.
    Berro A; Assi A; Farhat M; Hatoum L; Saad JP; Mohanna R; Bechara AMA; Prince G; Hachem MCR; Zalaquett Z; Kourie HR
    Crit Rev Oncol Hematol; 2024 Jun; 198():104365. PubMed ID: 38677355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin Affects Tumor Angiogenesis and Sensitizes Human Glioblastoma Endothelial Cells to Temozolomide, Bevacizumab, and Sunitinib, Impairing Vascular Endothelial Growth Factor-Related Signaling.
    Navone SE; Guarnaccia L; Cordiglieri C; Crisà FM; Caroli M; Locatelli M; Schisano L; Rampini P; Miozzo M; La Verde N; Riboni L; Campanella R; Marfia G
    World Neurosurg; 2018 Dec; 120():e380-e391. PubMed ID: 30144594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Development of Glioblastoma Therapeutic Agents.
    Wang Z; Peet NP; Zhang P; Jiang Y; Rong L
    Mol Cancer Ther; 2021 Sep; 20(9):1521-1532. PubMed ID: 34172531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic Screening of Chemical Libraries Enriched by Molecular Docking to Multiple Targets Selected from Glioblastoma Genomic Data.
    Xu D; Zhou D; Bum-Erdene K; Bailey BJ; Sishtla K; Liu S; Wan J; Aryal UK; Lee JA; Wells CD; Fishel ML; Corson TW; Pollok KE; Meroueh SO
    ACS Chem Biol; 2020 Jun; 15(6):1424-1444. PubMed ID: 32243127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ROS1 amplification mediates resistance to gefitinib in glioblastoma cells.
    Aljohani H; Koncar RF; Zarzour A; Park BS; Lee SH; Bahassi el M
    Oncotarget; 2015 Aug; 6(24):20388-95. PubMed ID: 25978031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery and Therapeutic Exploitation of Mechanisms of Resistance to MET Inhibitors in Glioblastoma.
    Cruickshanks N; Zhang Y; Hine S; Gibert M; Yuan F; Oxford M; Grello C; Pahuski M; Dube C; Guessous F; Wang B; Deveau C; Saoud K; Gallagher I; Wulfkuhle J; Schiff D; Phan S; Petricoin E; Abounader R
    Clin Cancer Res; 2019 Jan; 25(2):663-673. PubMed ID: 30201763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small Molecules Targeting Activated Cdc42-Associated Kinase 1 (ACK1/TNK2) for the Treatment of Cancers.
    Wang A; Pei J; Shuai W; Lin C; Feng L; Wang Y; Lin F; Ouyang L; Wang G
    J Med Chem; 2021 Nov; 64(22):16328-16348. PubMed ID: 34735773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small-molecule inhibitors of spleen tyrosine kinase as therapeutic agents for immune disorders: will promise meet expectations?
    Lucas MC; Tan SL
    Future Med Chem; 2014; 6(16):1811-27. PubMed ID: 25407369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel small-molecule inhibitors of glioblastoma cell growth and invasion by high-throughput screening.
    Wang L; Zhao H; Cui K; Yao L; Ren M; Hao A; Smollen P; Nie F; Jin G; Liu Q; Wong ST
    Biosci Trends; 2012 Aug; 6(4):192-200. PubMed ID: 23006966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of novel ACK1/TNK2 inhibitors using a fragment-based approach.
    Lawrence HR; Mahajan K; Luo Y; Zhang D; Tindall N; Huseyin M; Gevariya H; Kazi S; Ozcan S; Mahajan NP; Lawrence NJ
    J Med Chem; 2015 Mar; 58(6):2746-63. PubMed ID: 25699576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A combination of tyrosine kinase inhibitors, crizotinib and dasatinib for the treatment of glioblastoma multiforme.
    Nehoff H; Parayath NN; McConnell MJ; Taurin S; Greish K
    Oncotarget; 2015 Nov; 6(35):37948-64. PubMed ID: 26517812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The therapeutic potential of Aurora kinases targeting in glioblastoma: from preclinical research to translational oncology.
    de Almeida Magalhães T; de Sousa GR; Alencastro Veiga Cruzeiro G; Tone LG; Valera ET; Borges KS
    J Mol Med (Berl); 2020 Apr; 98(4):495-512. PubMed ID: 32219470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.